DEBUT BIOTECHNOLOGY, INC. — Form D
DEBUT BIOTECHNOLOGY, INC. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2020-09-14. The offering totals $2.7M, of which $2.2M was reported sold. Industry: Other Technology.
Offering
- Filed: 2020-09-14
- Form: D
- Accession: 0001798639-20-000003
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $2.7M
- Amount sold: $2.2M
- Remaining: $500K
- Investors: 7
- Date of first sale: 2020-09-04
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-375378
Issuer
- Name: DEBUT BIOTECHNOLOGY, INC.
- CIK: 0001798639
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 6330 NANCY RIDGE DR. UNIT 106, SAN DIEGO, CA, 92121
- Phone: (619) 432-5177
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Cain A McClary | Director | San Diego, CA |
| DANIEL A PHILLIPS | Director | SAN DIEGO, CA |
| JOSHUA BRITTON | Director | SAN DIEGO, CA |
| JOSHUA BRITTON | Executive Officer | SAN DIEGO, CA |
| CORINNA A CHEN | Director | SAN DIEGO, CA |
| GREGORY A WEISS | Executive Officer | SAN DIEGO, CA |
Other filings by this issuer (3)
More